← Back to Clinical Trials
Recruiting NCT07329426

NCT07329426 Effects of Muscle Energy Technique Combined With Mobilization in Patients With Sacral Torsion

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07329426
Status Recruiting
Phase —
Sponsor Foundation University Islamabad
Condition Sacral Torsion
Study Type INTERVENTIONAL
Enrollment 46 participants
Start Date 2025-01-15
Primary Completion 2025-12-30

Eligibility & Interventions

Sex All sexes
Min Age 22 Years
Max Age 44 Years
Study Type INTERVENTIONAL
Interventions
Muscle Energy Technique + Maitland MobilizationMaitland Mobilization

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 46 participants in total. It began in 2025-01-15 with a primary completion date of 2025-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Project Summary Low Back Pain is one of the most prevalent musculoskeletal conditions worldwide. More than 70% of the people experience low back pain at some time in their life. The sacroiliac joint has been found to be the source of pain in 30% of mechanical low back pain sufferers. Sacral torsion is one of the types of SIJ dysfunction. This randomized controlled trial, conducted at Fauji Foundation Hospital and Foundation University College of Physical Therapy will assess the effects of combining muscle energy technique with mobilization on pain, lumbar range of motion, disability and active straight leg raise. Participants will be randomly assigned to either mobilization alone or mobilization with muscle energy technique, performed three times per week for two weeks. Data will be collected at baseline and at end of study (week 2) using the Numeric pain rating scale, goniometer, inclinometer and oswestry disability index. This study addresses a research gap by exploring combined effects of muscle energy technique (PFS) and Maitland mobilization for sacral torsion in improving pain, lumbar mobility, disability and active straight leg raise.

Eligibility Criteria

Inclusion Criteria: * Age between 22- 44 years (18) * Both males and females * Clinically diagnosed sacral torsion. (Annexure E) * Patients with pain intensity of at least 5 on NPRS * Positive standing flexion test * Positive seated flexion test * Positive Gillet test * Uneven anatomical landmarks (Sacral Sulcus, Inferior Lateral Angle, Lumbar Lordosis, Lumbar scoliosis, L5 position) Exclusion Criteria: * 1\. Neurological deficits (hemiparesis, paralysis) 2. Pregnancy 3. Spinal surgery of any kind 4. Antero-Retro Spondylolisthesis diagnosed through radiological findings 5. Degenerative disc disease diagnosed through radiological findings 6. Spinal stenosis 7. Infection, tumors, osteoporosis, spinal fracture

Contact & Investigator

Central Contact

Hafiza Noor ul Huda, DPT

✉ hafiza.huda94@gmail.com

📞 03245475950

Frequently Asked Questions

Who can join the NCT07329426 clinical trial?

This trial is open to participants of all sexes, aged 22 Years or older, up to 44 Years, studying Sacral Torsion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07329426 currently recruiting?

Yes, NCT07329426 is actively recruiting participants. Contact the research team at hafiza.huda94@gmail.com for enrollment information.

Where is the NCT07329426 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07329426 clinical trial?

NCT07329426 is sponsored by Foundation University Islamabad. The trial plans to enroll 46 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology